Search
CMC and margins make cell and gene therapy a different kind of medicine
- blonca9
- Jan 18, 2023
- 1 min read
Updated: Jun 16, 2023
Dark Horse Consulting's Anthony Davies discusses CMC issues to consider when developing cell and gene therapies.
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.